Mechanisms of vaccine adjuvanticity at mucosal surfaces.
about
Recognition of Extracellular Bacteria by NLRs and Its Role in the Development of Adaptive ImmunityAdvances in swine immunology help move vaccine technology forward.Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickensLeptospirosis vaccines.Mouse models for the study of mucosal vaccination against otitis media.
P2860
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@ast
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@en
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@nl
type
label
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@ast
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@en
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@nl
prefLabel
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@ast
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@en
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
@nl
P1476
Mechanisms of vaccine adjuvanticity at mucosal surfaces
@en
P2093
M P Murtaugh
P356
10.1017/S1466252300000025
P577
2000-06-01T00:00:00Z